抗癌剂复方莪术油肝动脉栓塞治疗肝癌的疗效及临床评价  

Curative Effect and Clinical Evaluation of the Anticancer of Compound Zedoary Turmeric Oil Hepatic Artery Embolism in Treatment of Liver Cancer

作　　者：王国庆[1] 

机构地区：[1]河南省焦作市第二人民医院消化内科,河南焦作454000

出　　处：《中外医疗》2016年第4期110-111,共2页China & Foreign Medical Treatment

摘　　要：目的探讨抗癌剂复方莪术油肝动脉栓塞治疗肝癌的疗效。方法整群选取2012年3月—2013年4月间该院收治的肝癌患者120例,随机分成两组各60例,对照组给予单纯肝动脉化疗栓塞术,研究组则采取抗癌剂复方莪术油肝动脉栓塞治疗。结果研究组治疗近期有效率为91.67%,明显高于对照组66.67%的近期有效率,研究组3例出现不良反应,对照组10例出现不良反应,不良反应率显著低于对照组,对照组1、3、5年生存率分别为60%、31.67%和18.33%,研究组分别为81.67%、55%和41.67%,明显高于对照组,差异具有统计学意义,P<0.05。结论抗癌剂复方莪术油肝动脉栓塞治疗肝癌疗效显著,安全可靠。Objective To discuss the curative effect of the anticancer of compound zedoary turmeric oil hepatic artery embolism in treatment of liver cancer. Methods 120 cases of patients with liver cancer treated in our hospital from March2012 to April 2013 were selected and randomly divided into two groups with 60 cases in each, the control group were treated with the pure transcatheter arterial chemoembolization, the research group were treated with the anticancer of compound zedoary turmeric oil hepatic artery embolism. Results The treatment effective rate in short term in the research group was obviously higher than that in the control group（91.67% vs 66.67%）, the adverse reaction rate in the research group was obviously lower than that in the control group（ 3 cases vs 10 cases）, The 1-year, 3-year and 5-year survival rate in the research group were obviously higher than those in the control group（60%, 31.67% and 18.33% vs 81.67%,55% and41.67%）, and the differences were statistically significant P〈0.05. Conclusion The anticancer of compound zedoary turmeric oil hepatic artery embolism in treatment of liver cancer has an obvious curative effect and it is safe and reliable.

关 键 词：肝动脉栓塞 抗癌剂 复方莪术油 肝癌 

分 类 号：R5[医药卫生—内科学]